>>15375901 lb

Cont'd…

ALL ABOUT THE BENJIES, BABAY!

‘We need to increase public understanding of the need for medical countermeasures such as a pan-coronavirus vaccine. A key driver is the media and the economics will follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of the process.’ — Peter Daszak, Eco-Health Alliance

…

Before you actually have the thing on the 5th of June 2008 — which is an important date because it is actually around the time whenDARPA, the Defense Advanced Research Program in the United States, actively took an interest in coronavirus as abiological weapon— June 5th 2008 [Ablig], which as you know is now part of Sanofi, filed the series of patents that specifically targeted what we’ve been told is the novel feature of the SARS-CoV-2 virus, and you heard what I just said, this is the 5th of June 2008 they found the specific sequence they targeted, what was called the poly-basic cleavage site for SARS-CoV the novel spike protein in the ACE-2 receptor binding domain which is allegedly novel, to SARS-CoV-2, and all of that was patented on the 5th of June 2008. And those patents in sequence were issued between November 24th of 2015 which was U.S. Patent 919-3780, so that one came out after the gain-of-function moratorium. That one came after the MERS outbreak in the Middle East but what you find is that then in 2016, 2017, 2019 a series of patents all covering not only the RNA strands but also the subcomponents of the gene strands were all issued to [Ablig] and Sanofi and then we have Rubius Therapeutics, we have Children’s Medical Corporation, we have countless others that include Ludwig-Maximilians-University, Protein Science Corporation, Dana-Farber Cancer Institute, University of Iowa, University of Hong Kong, Chinese National Human Genome Center in Shanghai, all identifying in patent filings that ranged from 2008 until 2017 every attribute that was allegedly uniquely published by the single reference publication. The novel coronavirus reveals quote ‘natural insertions at the S1, S2 cleavage site of the spike protein and possible recombinant origin of the SARS-CoV-2 virus, the paper that has routinely been used to identify the novel virus.

Moar:

https://kamprint.com/realities/tag/bio-tech/

It's a transcript of what he says in video:

https://youtu.be/gsDlHprql-g

>>15376857 (me)

Goes with this one also, which made the notes earlier. >>15374530 pb

>>15376857 (me)

>>15374530 pb

Dr. Martin called it a while back.

And they began dealing with a very significant problem that they had which was they relied on technology that they did not own. Two Canadian companies Arbutus Pharmaceuticals and Acuitas Pharmaceuticals actually own the patent on the lipid nanoparticle envelope that’s required to deliver the injection of the mRNA fragment. And those patents have been issued both in Canada and in the U.S. and then around the world. Moderna knew that they did not own the rights and began trying to negotiate with Arbutus and Acuitas to make the lipid nanoparticle patented technology available to be put into a vaccine. And we know, before that in November they entered into a research and cooperative research and development agreement with UNC Chapel Hill with respect to getting the spike protein to put inside of the lipid nanoparticle so that they actually had a candidate vaccine before we had a pathogen allegedly that was running around.